-
Overview
-
Experience
Introduction
Arian counsels private and public companies, strategic venture funds, and institutional investors, helping close complex business transactions.
Arian S. Galavis counsels companies on domestic and international M&As, restructurings, equity financings, and other capital-raising transactions. He manages the transaction process, advising on corporate governance matters and drafting acquisition, stockholder, joint venture, and equity finance agreements.
Arian represents companies across a range of industries, with a focus on technology, life sciences, aerospace, and manufacturing. He represents clients including 98point6, Amazon.com, Avalara, Hinge Health, Intrinsic.ai, Microsoft, Pacira Pharmaceuticals, Valant Medical Solutions, and Worldly.
Education & credentials
- Boston University School of Law, J.D., cum laude, Managing Editor, Journal of Science and Technology Law, 2013
- Boston University School of Law, LL.M., Banking & Financial Law, 2014
- Pepperdine University, B.A., Economics & Piano Performance, cum laude, 2010
- Washington
- Massachusetts
- Choate, Hall & Stewart, LLP, Boston, MA, Associate, 2014-2017
Professional recognition
Named "Best-in-State, Washington - Mergers & Acquisitions", by Forbes, 2025
- Represented Xnor.ai in its sale to Apple Inc.
- Represented Boeing in its acquisition of Millennium Space Systems.
- Represented Microsoft in its acquisition of inXile Entertainment.
- Represented Pacira Pharmaceuticals in its $220,000,000 acquisition of MyoScience.
- Represented QuoteWizard in its $370,000,000 sale to LendingTree.
- Represented Zillow Group in its acquisition of Mortgage Lenders of America.
- Represented Adobe Systems in its acquisition of Sayspring.
- Represented Alta Forest Products in its sale to Itochu.
- Represented Esterline Technologies in the sale of its Kirkhill line of business.
Latest news, deals and awards
Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.
-
News Perkins Coie Advises Avalara on Acquisition of Versori
March 09, 2026
Discover more -
News Perkins Coie Advises Microsoft on Strategic Partnership with Anthropic and $5B Investment
November 20, 2025
Discover more -
News Perkins Coie Advises Storj on Acquisition by Inveniam Capital Partners
October 31, 2025
Discover more -
News Perkins Coie Advises Daring Foods in Acquisition by Australia’s v2food
August 18, 2025
Discover more -
News Perkins Coie Lawyers Recognized by Forbes for Client Excellence
June 26, 2025
Discover more -
News Perkins Coie Advises Pacira BioSciences, Inc. in Its Acquisition of GQ Bio Therapeutics
March 03, 2025
Discover more